Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,963 public trials 2,020 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma

NCT00478777

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Medizinische Klinik und Poliklinik II der Charité Universitätsmedizin Berlin Campus Mitte Berlin, Germany

Poliklinik I, Hämatologie/ Onkologie, Universitätsklinikum Bonn Bonn, Germany

Johanniter-Krankenhaus Bonn Friedrich-Wilhelm-Stift gGmbH Bonn, Germany

Medizinische Klinik Städtisches Klinikum Braunschweig gGmbH Braunschweig, Germany

View all 48 locations

View Trial Details

Completed

A Study to Compare Oxycodone/Naloxone Prolonged Release Against Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis

NCT00784810

Conditions: Arthritis, Back Pain, Hemic and Lymphatic Diseases, +17 more
Locations: Coventry, United Kingdom

View Trial Details

Completed

Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL

NCT00452374

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations: University of California-San Diego La Jolla, California, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma

NCT00038623

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Safety and Efficacy of Campath in Nonmyeloablative Transplantation

NCT00038844

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

The Effect of High Dose Simvastatine on Multiple Myeloma

NCT00281476

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Pulmonary Hypertension in Lymphangioleiomyomatosis

NCT00960895

Conditions: Cardiovascular Diseases, Hemic and Lymphatic Diseases, Hypertension, +16 more
Locations: Louis Pradel Hospital Lyon, University of Lyon, France

View Trial Details

Completed

Controlled Trial of Valacyclovir in Infectious Mononucleosis

NCT00274404

Conditions: DNA Virus Infections, Epstein-Barr Virus Infections, Hematologic Diseases, +11 more
Locations: University of Minnesota Clinical Virology Clinic Minneapolis, Minnesota, United States

View Trial Details

Completed

Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma

NCT01459887

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: SUN-YAT-SEN university cancer center Guangzhou, Guangdong, China

View Trial Details

Completed

Dose Escalation Study of ARQ 621 in Adult Patients With Metastatic Solid Tumors and Hematologic Malignancies

NCT00825487

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +25 more
Locations: Translational Genomics Institute Phoenix, Arizona, United States

Premiere Oncology Santa Monica, California, United States

Boston, Massachusetts, United States

Nevada Cancer Institute Las Vegas, Nevada, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions